Successful early treatment combining remdesivir with high‐titer convalescent plasma among COVID‐19‐infected hematological patients-Reference-Cited by-同舟云学术

Successful early treatment combining remdesivir with high‐titer convalescent plasma among COVID‐19‐infected hematological patients

Published:2021-08-16 Issue:5 Volume:39 Page:715-720
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Weinbergerova Barbora¹²^ORCID,Mayer Jiri¹²,Kabut Tomas¹²,Hrabovsky Stepan¹²,Prochazkova Jirina¹²,Kral Zdenek¹²,Herout Vladimir³⁴,Pacasova Rita⁵⁶,Zdrazilova‐Dubska Lenka⁷,Husa Petr⁸⁹,Bednar Petr¹⁰¹¹,Ruzek Daniel¹⁰¹²,Lengerova Martina¹²

Affiliation:

1. Department of Internal Medicine—Hematology and Oncology Masaryk University Brno Czech Republic

2. Department of Internal Medicine—Hematology and Oncology University Hospital Brno Brno Czech Republic

3. Department of Respiratory Diseases Masaryk University Brno Czech Republic

4. Department of Respiratory Diseases University Hospital Brno Brno Czech Republic

5. Transfusion and Tissue Department Masaryk University Brno Czech Republic

6. Transfusion and Tissue Department University Hospital Brno Brno Czech Republic

7. Department of Clinical Microbiology and Immunology University Hospital Brno Brno Czech Republic

8. Department of Infectious Diseases Masaryk University Brno Czech Republic

9. Department of Infectious Diseases University Hospital Brno Brno Czech Republic

10. Veterinary Research Institute Brno Czech Republic

11. Faculty of Science University of South Bohemia Ceske Budejovice Czech Republic

12. Institute of Parasitology Biology Centre of the Czech Academy of Sciences Ceske Budejovice Czech Republic

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2908

Reference10 articles.

1. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

2. Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set

3. Remdesivir for the Treatment of Covid-19 — Final Report

4. A shorter symptom onset to remdesivir treatment (SORT) interval is associated with a lower mortality in moderate-to-severe COVID-19: A real-world analysis

5. Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous immunoglobulins for the treatment of prolonged COVID-19 in immunocompromised patients: a brief report;Frontiers in Immunology;2024-04-19

2. Safety and Efficacy of Convalescent Plasma Combined with Other Pharmaceutical Agents for Treatment of COVID-19 in Hospitalized Patients: A Systematic Review and Meta-Analysis;Diseases;2024-02-21

3. COVID-19 in Adult Patients with Hematological Malignancies—Lessons Learned after Three Years of Pandemic;Biology;2023-04-03

4. ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products;Clinical and Experimental Rheumatology;2023-03-02

5. SARS-CoV-2 Genome Variations in Viral Shedding of an Immunocompromised Patient with Non-Hodgkin’s Lymphoma;Viruses;2023-01-28